Device
Cemented hemiarthroplasty
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Other(3)
Detailed Status
unknown3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown3100%
Recent Activity
0 active trials
Showing 3 of 3
unknownnot_applicable
Fixation Versus Arthroplasty for Undisplaced Intracapsular Fractures
NCT02996383
unknownnot_applicable
Hemiarthroplasty Compared to Total Hip Arthroplasty for Displaced Femoral Neck Fractures in the Elderly-elderly
NCT02246335
unknownphase_2
Hip Fractures Treated With Uncemented Arthroplasties
NCT01798472
Clinical Trials (3)
Showing 3 of 3 trials
NCT02996383Not Applicable
Fixation Versus Arthroplasty for Undisplaced Intracapsular Fractures
NCT02246335Not Applicable
Hemiarthroplasty Compared to Total Hip Arthroplasty for Displaced Femoral Neck Fractures in the Elderly-elderly
NCT01798472Phase 2
Hip Fractures Treated With Uncemented Arthroplasties
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3